NEW ORLEANS -- Different techniques had their place in coronary artery bypass grafting (CABG), real-world studies affirmed here at the annual meeting of the Society of Thoracic Surgeons (STS). In one ...

Please provide your email address to receive an email when new articles are posted on . The price of CABG was not associated with adverse outcomes or CMS or patient rankings. Cost was higher at ...

Please provide your email address to receive an email when new articles are posted on . CABG/surgical AVR was tied to lower risk for stroke, MI, valve reintervention or death vs. PCI/TAVR for aortic ...

In-hospital silent asymptomatic graft occlusion following coronary artery bypass grafting (CABG) was associated with an increased incidence of angina-related rehospitalisations and reinterventions ...

MADRID, Spain—Adding evolocumab (Repatha; Amgen) to statin therapy does not lower the risk of saphenous vein graft (SVG) failure among patients who undergo coronary artery bypass surgery, the ...

A small Chinese trial compared the effects of three oral antispastic medications for 24 weeks post-coronary artery bypass grafting (CABG) in relation to spasm-induced radial artery graft failure.

Addition of the PCSK9 inhibitor evolocumab to statin therapy after cardiac bypass surgery did not improve 24-month graft patency in the NEWTON-CABG CardioLink-5 trial. Subodh Verma, MD, cardiac ...

Receive the the latest news, research, and presentations from major meetings right to your inbox. TCTMD ® is produced by the Cardiovascular Research Foundation ® (CRF). CRF ® is committed to igniting ...